Please login to the form below

Not currently logged in

B.1.351 variant

This page shows the latest B.1.351 variant news and features for those working in and with pharma, biotech and healthcare.

EMA begins rolling review of Sanofi, GSK’s COVID-19 vaccine

EMA begins rolling review of Sanofi, GSK’s COVID-19 vaccine

another formulation targeting the Beta or B.1.351 variant. ... Last year, Sanofi and GSK delayed the COVID-19 vaccine programme after the jointly developed candidate induced low immune responses in older adults in a phase 1/2 study.

Latest news

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....